The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells.
The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells.
复制标题
DOI:
10.1161/atvbaha.110.214916
复制
发表时间:
2011-01
期刊:
影响因子:
--
通讯作者:
Autieri MV
中科院分区:
文献类型:
--
作者:
Jain S;Gabunia K;Kelemen SE;Panetti TS;Autieri MV
The expression and effects of anti-inflammatory interleukins on endothelial cell (EC) activation and development of angiogenesis is uncharacterized. The purpose of this study is to characterize the expression and function of Interleukin-19 (IL-19), a recently described Th2 anti-inflammatory interleukin on EC pathophysiology. We demonstrate by immunohistochemistry and immunoblot that IL-19 is expressed in inflamed, but not normal human coronary endothelium, and can be induced in cultured human EC by serum and bFGF. IL-19 is mitogenic, chemotactic, and promotes cell EC spreading. IL-19 activates the signaling proteins STAT3, p44/42, and Rac1. In functional ex vivo studies, IL-19 promotes cord-like structure formation of cultured EC and also enhances microvessel sprouting in the mouse aortic ring assay. IL-19 induces tube formation in matrigel plugs in vivo. These data are the first to report expression of the anti-inflammatory interleukin IL-19 in EC, and the first to indicate that IL-19 is mitogenic and chemotactic for EC, and can induce the angiogenic potential of EC.